EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Real-world utilization pattern of dydrogesterone in 7287 Indian women with obstetric and gynecological conditions: data from multicentric, retrospective study

Jaydeep Tank iD, Sanjay Gupte iD, Purna Chandra Mahapatra iD, Jayanthi Reddy iD, Pratima Mittal iD, Ashish Kumar Mukhopadhyay iD, Lila Vyas iD, Achla Batra iD, Mahesh Gupta iD, Sunita Tandulwadkar iD, Sunita Chandra iD, Vidya Bhat iD und 4 weitere

Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics · 2024

DOI: 10.61622/rbgo/2024ao18 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, 2024. Verfasst von Jaydeep Tank und 15 weiteren Autor:innen. Beteiligte Einrichtung: Ashwini Maternity and Surgical Hospital Mumbai India Ashwini Maternity and Surgical Hospital, Mumbai, India. Hauptthemen laut MEDLINE: Dydrogesterone, Progestins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Despite the literature on dydrogesterone, studies on dydrogesterone utilization patterns are largely lacking in Indian patients.

Methods

This was a multi-center, retrospective, observational, cross-sectional, and descriptive study across 817 centers in India. Data of patients who received dydrogesterone in past and provided consent for future use of their medical record for research purpose was were retrieved and analyzed.

Results

Data of 7287 subjects (aged 29.55±4.84 years) was analyzed. Threatened abortion was the most common indication for which the subjects received dydrogesterone (46.9%) followed by recurrent pregnancy loss. Polycystic ovary syndrome (PCOS), thyroid disorders and anemia were the most common comorbid conditions and prior pregnancy loss, advanced maternal age and obesity were the most common risk factors seen in subjects who received dydrogesterone. Total 27.5% of subjects received a loading dose of dydrogesterone, and majority (64%) received 40 mg as loading dose. 10 mg dose was used as maintenance or regular dose in 81.4% of the subjects. Twice daily (BID) was the most common dosing frequency (66.6%). The most common concomitant medications being taken by the subjects on dydrogesterone included folic acid (45.1%), iron supplements (30.3%) and calcium and vitamin D3 supplements (25.5%). Another progesterone preparation (oral, injection, vaginal, tubal) other than dydrogesterone was used concurrently in 7.8% of subjects.

Conclusion

The study helped to identify the patient population that is benefitted by dydrogesterone and the preferred indications, risk factors, comorbid conditions and concomitant medication used in this patient population at real-life scenario.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DydrogesteroneProgestinsHumansFemaleRetrospective StudiesIndiaAdultCross-Sectional StudiesPregnancyYoung AdultAbortion, ThreatenedAbortion, Habitual

Stichwörter der Autor:innen

Comorbid conditionsConcomitant medicationsDydrogesteroneGynecological conditionsIndian womenRisk factorsThreatened abortionUtilization pattern

Substanzen

DydrogesteroneProgestins

Autor:innen und Institutionen

  • Ashwini Maternity and Surgical Hospital Mumbai India Ashwini Maternity and Surgical Hospital, Mumbai, India.
  • Gupte Hospital and Centre for Research in Reproduction Pune - Obstetrics and Gynecology PuneMaharashtra India Gupte Hospital and Centre for Research in Reproduction, Pune - Obstetrics and Gynecology, Pune, Maharashtra,…
  • Prachee Nursing Home Cuttack India Prachee Nursing Home, Cuttack, India.
  • J. J. Hospital Hyderabad India J. J. Hospital, Hyderabad, Hyderabad, India.
  • Vardhman Mahavir Medical College and Safdarjung Hospital New Delhi India Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
  • CSS College of Obstetrics Kolkata India CSS College of Obstetrics, Gynae. & Child health, Kolkata, India.

ORCID-Profile: Jaydeep Tank, Sanjay Gupte, Purna Chandra Mahapatra, Jayanthi Reddy, Pratima Mittal, Ashish Kumar Mukhopadhyay, Lila Vyas, Achla Batra, Mahesh Gupta, Sunita Tandulwadkar, Sunita Chandra, Vidya Bhat, Kawita Bapat, Parikshit Tank, Ketan Kulkarni, Onkar Swami

Zitieren

APA

Tank, J., Gupte, S., Mahapatra, P. C., Reddy, J., Mittal, P., Mukhopadhyay, A. K., Vyas, L., Batra, A., Gupta, M., Tandulwadkar, S., Chandra, S., Bhat, V., Bapat, K., Tank, P., Kulkarni, K., & Swami, O. (2024). Real-world utilization pattern of dydrogesterone in 7287 Indian women with obstetric and gynecological conditions: data from multicentric, retrospective study. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. https://doi.org/10.61622/rbgo/2024ao18

Vancouver

Tank J, Gupte S, Mahapatra PC, Reddy J, Mittal P, Mukhopadhyay AK, et al. Real-world utilization pattern of dydrogesterone in 7287 Indian women with obstetric and gynecological conditions: data from multicentric, retrospective study. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. 2024. doi:10.61622/rbgo/2024ao18

BibTeX
@article{Tank2024,
  author = {Tank, Jaydeep and Gupte, Sanjay and Mahapatra, Purna Chandra and Reddy, Jayanthi and Mittal, Pratima and Mukhopadhyay, Ashish Kumar and Vyas, Lila and Batra, Achla and Gupta, Mahesh and Tandulwadkar, Sunita and Chandra, Sunita and Bhat, Vidya and Bapat, Kawita and Tank, Parikshit and Kulkarni, Ketan and Swami, Onkar},
  title = {Real-world utilization pattern of dydrogesterone in 7287 Indian women with obstetric and gynecological conditions: data from multicentric, retrospective study},
  journal = {Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics},
  year = {2024},
  doi = {10.61622/rbgo/2024ao18}
}
Kostenlos starten →